BPC 157 and TB 500: Injury Healing Peptides Jonathan L. Glashow posted on the topic LinkedIn BPC 157 Banned: Key Facts on the Latest FDA Decision The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA to weigh easing limits on peptides promoted by RFK Jr. NBC 6 South Florida Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law